Cognistem Biosciences

San Diego, United States Founded: 2020 • Age: 6 yrs
Develops iPS-derived neuronal models for Alzheimers disease studies.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 7 Brand Intelligence

About Cognistem Biosciences

Cognistem Biosciences is a company based in San Diego (United States) founded in 2020. It operates as a B2B. Cognistem Biosciences offers products and services including iPS-derived Neuronal Models. Cognistem Biosciences operates in a competitive market with competitors including bit.bio, Herophilus, Epiloid Biotechnology, Norganoid and Neurxstem, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Cognistem Biosciences, Llc
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cognistem Biosciences

Cognistem Biosciences offers a comprehensive portfolio of products and services, including iPS-derived Neuronal Models.

Product name locked
Category locked
Primary

Tools for studying Alzheimer's disease phenotypes using patient cells.

Funding Insights of Cognistem Biosciences

Premium access

Detailed funding history for Cognistem Biosciences

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Cognistem Biosciences

Investments
Premium access

Investment portfolio details for Cognistem Biosciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Cognistem Biosciences

Premium access

Detailed financials for Cognistem Biosciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cognistem Biosciences Comparisons

Cognistem Biosciences Primary company
Description
Develops iPS-derived neuronal models for Alzheimer's disease...
Location
San Diego, United States
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Cognistem Biosciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Cognistem Biosciences

Cognistem Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as bit.bio, Herophilus, Epiloid Biotechnology, Norganoid and Neurxstem, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of a platform for synthetic and stem cell therapies
Locked Locked Locked
Developer of drug discovery platform to treat neurological disorders
Locked Locked Locked
3D cerebral organoid assays are provided for neurological drug testing.
Locked Locked Locked
Brain-on-chip solutions are developed to accelerate drug research.
Locked Locked Locked
Neural organoid platform is developed from iPSC for brain research.
Premium access

Detailed competitors of Cognistem Biosciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cognistem Biosciences

Premium access

Complete news archive for Cognistem Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cognistem Biosciences

Cognistem Biosciences was founded in 2020.

Cognistem Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Cognistem Biosciences, LLC, based in La Jolla, California, develops induced pluripotent stem cell-derived neuronal models to study Alzheimers disease phenotypes. Using patient-derived cells, they create tools for personalized diagnostics and therapeutic drug development. The company models disease subtypes in neurons and 3D cerebral organoids to understand onset, progression, and test therapies, focusing on advancing medical research.

Cognistem Biosciences's top competitors include bit.bio, Herophilus and Epiloid Biotechnology.

Cognistem Biosciences offers iPS-derived Neuronal Models.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available